BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN
17403 results:

  • 1. [Identification of key genes in Wilms tumor based on high-throughput RNA sequencing and their impacts on prognosis and immune responses].
    Gao Z; Lin J; Hong P; Hu Z; Dong J; Shi Q; Tian X; Liu F; Wei G
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):727-738. PubMed ID: 38708507
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Does depressurization of the portal vein before liver transplantation affect the recurrence of HCC? A nested case-control study.
    Wei G; Zhao Y; Feng S; Yuan J; Xu G; Lv T; Yang J; Kong L; Yang J
    BMC Cancer; 2024 May; 24(1):558. PubMed ID: 38702621
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Epidemiology, treatment and outcomes of primary renal sarcomas in adult patients.
    Uhlig J; Uhlig A; Deshpande H; Ströbel P; Trojan L; Lotz J; Hurwitz M; Hafez O; Humphrey P; Grünwald V; Kim HS
    Sci Rep; 2024 May; 14(1):10038. PubMed ID: 38693188
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma.
    Rahman SN; Long JB; Westvold SJ; Leapman MS; Spees LP; Hurwitz ME; McManus HD; Gross CP; Wheeler SB; Dinan MA
    JAMA Netw Open; 2024 Apr; 7(4):e248747. PubMed ID: 38687479
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Increased level of serum leucine-rich-alpha-2-glycoprotein 1 in patients with clear cell renal cell carcinoma.
    Nakanishi S; Goya M; Suda T; Yonamine T; Sugawa A; Saito S
    BMC Urol; 2024 Apr; 24(1):94. PubMed ID: 38658967
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Modern view on the problem of diagnostics of renal angiomioadenomatous tumor].
    Osmanov Y I; Kogan E A; Gadzhieva Z K; Radenska-Lopovok S G; Prochenko D D
    Urologiia; 2024 Mar; (1):92-95. PubMed ID: 38650412
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comparison of skin cancer risk between renal transplant recipients and patients with glomerular diseases in rural Queensland.
    Thet Z; Lam AK; Ng SK; Aung SY; Han T; Ranganathan D; Newsham S; Borg J; Pepito C; Khoo TK
    Aust J Rural Health; 2024 Apr; 32(2):249-262. PubMed ID: 38646861
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
    Choueiri TK; Tomczak P; Park SH; Venugopal B; Ferguson T; Symeonides SN; Hajek J; Chang YH; Lee JL; Sarwar N; Haas NB; Gurney H; Sawrycki P; Mahave M; Gross-Goupil M; Zhang T; Burke JM; Doshi G; Melichar B; Kopyltsov E; Alva A; Oudard S; Topart D; Hammers H; Kitamura H; McDermott DF; Silva A; Winquist E; Cornell J; Elfiky A; Burgents JE; Perini RF; Powles T;
    N Engl J Med; 2024 Apr; 390(15):1359-1371. PubMed ID: 38631003
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Single nucleotide polymorphism (SNP) chromosomal microarray as a diagnostic tool for mucinous tubular and spindle cell carcinoma: A validation study.
    Nielson KJ; Rowsey R; Dasari S; Sukov WR; Kipp BR; Raghunathan A; Whaley RD; Ebare K; Stanton ML; Reynolds JP; Sharma V; Thompson RH; Boorjian SA; Leibovich BC; Hernandez LH; Jimenez RE; Cheville JC; Gupta S
    Hum Pathol; 2024 Apr; 146():57-65. PubMed ID: 38615998
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical safety and efficacy of microwave ablation for small renal masses.
    Foret A; Haaga CB; Jain S; Baumgartner CO; Escott M; Henderson BR; O'Brien ST; Delacroix SE; Gills JRR; Westerman ME
    Int Braz J Urol; 2024; 50(3):277-286. PubMed ID: 38598830
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Discussion on the surgical timing of rupture and hemorrhage of renal angiomyolipoma].
    Chen K; Deng S; Liu Z; Zhang H; Ma L; Zhang S
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Apr; 56(2):326-331. PubMed ID: 38595253
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Conversion to Radical Nephrectomy From Robotic Partial Nephrectomy Is Most Commonly Due to Anatomic and Oncologic Complexity.
    Wang Y; Wilder S; Butaney M; Hijazi M; Gandham D; Van Til M; Goldman B; Qi J; Mirza M; Johnson A; Rudoff M; Wenzler D; Rogers CG; Lane BR
    J Urol; 2024 May; 211(5):669-676. PubMed ID: 38591701
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Challenges and technical aspects in the management of muscle invasive bladder cancer as retrograde radical cystectomy with ileal conduit.
    Nusrat NB; Rehman AU; Zafar N; Muhammad S; Bajwa SI; Imtiaz S
    J Pak Med Assoc; 2024 Mar; 74(3):513-518. PubMed ID: 38591289
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. MiR-574-5p activates human TLR8 to promote autoimmune signaling and lupus.
    Wang T; Song D; Li X; Luo Y; Yang D; Liu X; Kong X; Xing Y; Bi S; Zhang Y; Hu T; Zhang Y; Dai S; Shao Z; Chen D; Hou J; Ballestar E; Cai J; Zheng F; Yang JY
    Cell Commun Signal; 2024 Apr; 22(1):220. PubMed ID: 38589923
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Intracorporeal versus extracorporeal anastomosis in laparoscopic right hemicolectomy for overweight colon cancer patients: a case-control study.
    Zhou D; Su J; Yang X; Huang L; Zheng Z; Wei H; Fang J
    Langenbecks Arch Surg; 2024 Apr; 409(1):112. PubMed ID: 38587671
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Transfusions of packed red blood cells in surgery for liver cancer: predictor of impaired overall survival but not recurrence-free survival - impact of blood transfusions in liver surgery.
    Giehl-Brown E; Geipel E; Löck S; Dehlke K; Schweipert J; Weitz J; Riediger C
    J Gastrointest Surg; 2024 Apr; 28(4):402-411. PubMed ID: 38583890
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Percutaneous Nephrostomy as a Procedure in the Treatment of Urinary Tract Obstruction - Experiences in the University Clinic of Urology in Skopje.
    Trifunovski A; Severova G; Atanasova A; Janculev J; Stankov V; Stavridis S; Saidi S; Brzanov AG; Ambardjieva M; Dohchev S
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2024 Mar; 45(1):31-40. PubMed ID: 38575377
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Renal anatomical classification systems cannot predict the occurrence of vascular complications after partial nephrectomy.
    Xu P; Yang G; Pan L; Zhu Y; Zhang S; Li Y; He M; Huang J; Jiang S; Hu X; Guo J; Cheng J; Wang H
    World J Urol; 2024 Apr; 42(1):208. PubMed ID: 38565733
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Predictive factors of renal function after robot-assisted partial nephrectomy in clinical T1b tumors.
    Yamamoto R; Numakura K; Kobayashi M; Nara T; Saito M; Narita S; Habuchi T
    J Robot Surg; 2024 Apr; 18(1):154. PubMed ID: 38564051
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
    Machiels JP; Tao Y; Licitra L; Burtness B; Tahara M; Rischin D; Alves G; Lima IPF; Hughes BGM; Pointreau Y; Aksoy S; Laban S; Greil R; Burian M; Hetnał M; Delord JP; Mesía R; Taberna M; Waldron JN; Simon C; Grégoire V; Harrington KJ; Swaby RF; Zhang Y; Gumuscu B; Bidadi B; Siu LL;
    Lancet Oncol; 2024 May; 25(5):572-587. PubMed ID: 38561010
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 871.